Connect with Top-Rated Pharmacies in Cambridge!

X4 Pharmaceuticals is a biotechnology company that develops and commercializes innovative therapies for patients with rare diseases of the immune system and significant unmet needs. The company has received US approval for XOLREMDI (mavorixafor) in its first indication and is currently advancing mavorixafor for additional patient populations. With a focus on CXCR4 and immune system biology, X4 Pharmaceuticals leverages expertise from its corporate headquarters in Boston and research center of excellence in Vienna to advance its patient-centric mission.

Boston Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing highly engineered therapies to transform the lives of patients who fight serious liver diseases. We are driven by a passion for excellence and a commitment to patients. Our team of experienced professionals is dedicated to accelerating the pipeline of medicines to patients. We partner with biotechnology and pharmaceutical companies to acquire innovative drug candidates and advance only those programs that meet our stringent development hurdles. With a portfolio focused on liver-disease, we strive to make rigorous and timely decisions to bring life-improving medicines to patients.